Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves. Issue 4 (23rd March 2022)

• Record Type: Journal Article
• Authors: Jensen, Rebekka Vibjerg; Jensen, Jesper Khedri; Christiansen, Evald Høj; Tang, Mariann; Nielsen, Jens Cosedis; Terkelsen, Christian Juhl
• Editors: Shaheen, Sameh; Deharo, Pierre; Montalto, Claudio; Amin, Reshma; Djahit, Ayse
• Is Part Of: European heart journal. Volume 6:Issue 4(2022)
• Publication Date: 2022-03-23
• Subjects: Transcatheter valve implantation -- Tricuspid bioprosthesis failure -- Tricuspid valve stenosis -- Valve-in-valve -- Case report -- Transjugular access; Cardiology -- Periodicals; Cardiology -- Case studies -- Periodicals; Heart -- Diseases -- Periodicals; Heart -- Diseases -- Case studies -- Periodicals; 616.12
• DOI: 10.1093/ehjcr/ytac131
• Languages: English
• ISSNs: 2514-2119

Abstract

Abstract: Background: Patients with severe tricuspid valve stenosis or dysfunction following degeneration of biological valve prosthesis in tricuspid position are complex, have substantial comorbidity, and very high surgical risk. Case summary: We report two cases with transcatheter tricuspid valve-in-valve implantation in patients with degenerated tricuspid bioprosthesis with transfemoral and transjugular access with Sapien 3 valve and MyVal, respectively. Discussion: In patients with high surgical risk, transcatheter tricuspid valve implantation is a good alternative. Careful consideration of optimal access site, device size, and delivery system is paramount. This case report demonstrates technically feasible and safe transcatheter valve-in-valve implantantion in tricuspid position and highlights the importance of meticulous procedure planning.